StockData
Aprea Therapeutics, Inc. logo

Aprea Therapeutics, Inc. (APRE) stock

APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$0.46+0.01 (+2.60%)

Close on Nov 18, 2026Market cap $5.85MP/E –Yield –

Aprea Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aprea Therapeutics's price to book ratio was 0.1× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.1× to 1.9×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−0.3
2025Dec 31, 20250.5×−0.3
2024Dec 31, 20240.8×−0.1
2023Dec 29, 20230.9×+0.2
2022Dec 30, 20220.6×−0.5
2021Dec 31, 20211.1×−0.0
2020Dec 31, 20201.2×–

More Aprea Therapeutics figures

See a number that looks wrong?